- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04381000
Quarantine and Telerehabilitation in Chronic Pain Patients During COVID-19 Pandemic.
June 30, 2020 updated by: Clinical Exercise Physiology and Rehabilitation Reasearch Laboratory
The Impact of Quarantine and the Effectiveness of Telerehabilitation in Patients With Chronic Pain During COVID-19 Pandemic.
The quarantine during COVID-19 pandemic has changed daily routine.
Staying at home for prolonged periods of time can pose a significant challenge for patients with chronic pain.
The purpose of the current study is to investigate how the quarantine effects of psychosocial factors, quality of life, sleep, nutrition and physical activity in patients with chronic musculoskeletal pain.
Another purpose is to examine whether a telerehabilitation exercise program is effective during the lockdown period.
Study Overview
Detailed Description
Participants, both male and female, with chronic musculoskeletal pain for at least 3 months will be included in the study.
They will complete some questions about anxiety, depression, sleep, nutrition, quality of life, pain behavior and characteristics, illness perceptions, functioning and daily routine.
Questionnaires will be completed twice (first and last week of quarantine, 40 days of duration).
A group of patients will follow an exercise program during this time.
It will be evaluated the link between the question of physical and psychological factors in the experience of pain in quarantine situation and, also, it will examine whether a telerehabilitation exercise program is effective during the lockdown period.
Study Type
Interventional
Enrollment (Actual)
170
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Sterea Ellada
-
Lamia, Sterea Ellada, Greece, 35100
- Clinical Exercise Physiology and Rehabilitation Laboratory
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 80 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patient with chronic musculoskeletal pain (Chronic pain will be defined as pain lasting for 3 or more months. Also, pain intensity will be at least 3 on a 0-10 numerical pain rating scale on most days of the last 3 months).
- Patient with sufficient understanding of the Greek language
Exclusion Criteria:
- Patients without being at quarantine
- Systemic diseases such as rheumatoid arthritis, fibromyalgia and/or polymyalgia rheumatic
- Osteoporosis, haemophilia and/or cancer
- Recent surgery or trauma
- Being pregnant or given birth in the preceding year
- Cognitive impairment
- Inability to provide informed consent and/or complete written questionnaires
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
No Intervention: Control Group
The control group will not participate in any exercise program.
|
|
Experimental: Intervention
The intervention group will participate in an exercise program for 6 weeks/ 2 sessions per week, for a total of 12 sessions of 30-45 minutes each.
|
The group follows warm up exercise (maximum 10 minutes).
This consisted of combined, breathing techniques, low-impact aerobic exercises, free range of motion exercises of upper and lower limbs and spine, and coordination-based exercises of hands and feet.
Breathing techniques take regular activities such as sitting, walking, and lying down.
At the end of this phase, active stretching exercises of major muscles of arm, leg and trunk were performed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Anxiety and Depression
Time Frame: Change From Baseline in HADS at 40 days
|
To measure the levels of anxiety and depression Hospital Anxiety and Depression Scale (HADS), will be used.
Patients have to score 14 opinions.
Seven of the items relate to anxiety and seven relate to depression.
A cut-off point of 8/21 for anxiety or depression has been recommended.
|
Change From Baseline in HADS at 40 days
|
Quality of Life and overall health
Time Frame: Change From Baseline in EQ-5D-3L at 40 days
|
To measure quality of life, EQ-5D-3L will be used.
The EQ-5D-3L essentially consists of 2 pages: the EQ-5D descriptive system and the EQ visual analogue scale (EQ VAS).
The EQ-5D-3L descriptive system comprises the following five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression.
Each dimension has 3 levels: no problems, some problems, and extreme problems.
The patient is asked to indicate his/her health state by ticking the box next to the most appropriate statement in each of the five dimensions.
This decision results into a 1-digit number that expresses the level selected for that dimension.
The digits for the five dimensions can be combined into a 5-digit number that describes the patient's health state.
|
Change From Baseline in EQ-5D-3L at 40 days
|
Pain Intensity
Time Frame: Change From Baseline in NPRS Scores at 40 days
|
The Numeric Pain Rating Scale (NPRS) is a unidimensional measure of pain intensity in adults and it will be used in the current study.
The most commonly used is the 11-item NPRS.
The 11-point numeric scale ranges from '0' representing one pain extreme (e.g.
"no pain") to '10' representing the other pain extreme (e.g.
"pain as bad as you can imagine" or "worst pain imaginable").The NPRS is a valid and reliable scale to measure pain intensity.
In this study, will rate current pain intensity and mean pain intensity during the past 7 days.
|
Change From Baseline in NPRS Scores at 40 days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Quality and patterns of sleep
Time Frame: Change From Baseline in PSQI Scores at 40 days
|
The Pittsburgh Sleep Quality Index (PSQI) is an effective instrument used to measure the quality and patterns of sleep in the older adult.
PSQI will be used to assess quality and patterns of sleep in the current study.
PSQI differentiates "poor" from "good" sleep by measuring seven domains: subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, sleep disturbances, use of sleep medication, and daytime dysfunction over the last month.
The client self-rates each of these seven areas of sleep.
Scoring of the answers is based on a 0 to 3 scale, whereby 3 reflects the negative extreme on the Likert Scale.
A global sum of "5" or greater indicates a "poor" sleeper.
Although there are several questions that request the evaluation of the client's bed mate or roommate, these are not scored, nor reflected in the attached instrument.
An update to the scoring: if 5 is not complete or the value is missing, it now counts as a "0".
|
Change From Baseline in PSQI Scores at 40 days
|
Patients' illness perceptions
Time Frame: Change From Baseline in BIPQ Scores at 40 days
|
Patients' illness perceptions will be measured based on the Brief Illness Perception Questionnaire (BIPQ).
The patient has to rate 8 statements on a 10-point scale (1-10).
The higher the score, the greater is the extent to which the patient's illness perceptions are threatening him or her.
|
Change From Baseline in BIPQ Scores at 40 days
|
Disability
Time Frame: Change From Baseline in ODI Scores at 40 days
|
Disability will be assessed using Oswestry Disability Index (ODI) that present ten sections cover Pain, Personal Care, Lifting, Walking, Sitting, Standing, Sleeping, Sex Life, Social Life, and Traveling.
Each section has six statements reflecting an increasing level of disability.
Respondents choose the statement that most applies to them in each section.
The first statement is scored 0; the second is scored 1 and so on to 5 for the last statement.
The sum of the section scores is divided by 50 if all sections are completed and multiplied by 100 for the final percentage score.
|
Change From Baseline in ODI Scores at 40 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Study Chair: Eleni V Kapreli, MSc,PhD, Clinical Exercise Physiology & Rehabilitation Laboratory,University of Thessaly
- Principal Investigator: Georgios Tsatsakos, PhD, TherapyLab
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Torales J, O'Higgins M, Castaldelli-Maia JM, Ventriglio A. The outbreak of COVID-19 coronavirus and its impact on global mental health. Int J Soc Psychiatry. 2020 Jun;66(4):317-320. doi: 10.1177/0020764020915212. Epub 2020 Mar 31.
- Hawryluck L, Gold WL, Robinson S, Pogorski S, Galea S, Styra R. SARS control and psychological effects of quarantine, Toronto, Canada. Emerg Infect Dis. 2004 Jul;10(7):1206-12. doi: 10.3201/eid1007.030703.
- Chatterjee K, Chauhan VS. Epidemics, quarantine and mental health. Med J Armed Forces India. 2020 Apr;76(2):125-127. doi: 10.1016/j.mjafi.2020.03.017. Epub 2020 Apr 22. No abstract available.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 1, 2020
Primary Completion (Actual)
May 29, 2020
Study Completion (Actual)
June 10, 2020
Study Registration Dates
First Submitted
May 7, 2020
First Submitted That Met QC Criteria
May 7, 2020
First Posted (Actual)
May 8, 2020
Study Record Updates
Last Update Posted (Actual)
July 1, 2020
Last Update Submitted That Met QC Criteria
June 30, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 3
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Pain
-
Pain ConcernThe Thistle Foundation; Health and Social Care Alliance Scotland (the ALLIANCE) and other collaboratorsCompletedChronic Pain | Chronic Pain Syndrome | Chronic Pain, Widespread | Chronic Pain Due to Trauma | Chronic Pain Due to Malignancy (Finding) | Chronic Pain Due to Injury | Chronic Pain Post-Procedural | Chronic Pain HipUnited Kingdom
-
Consorci Sanitari de l'Alt Penedès i GarrafRecruitingChronic Post Operative Pain | Chronic Post-surgical Pain | Chronic Knee PainSpain
-
Dow University of Health SciencesRecruitingLow Back Pain | Chronic Low-back Pain | Low Back Pain, Mechanical | Mechanical Low Back Pain | Pain, Chronic | Pain, Back | Lower Back Pain Chronic | CLBP - Chronic Low Back PainPakistan
-
University of Alabama, TuscaloosaPatient-Centered Outcomes Research Institute; East Carolina University; Whatley...CompletedPain | Chronic Pain | Chronic Pain Syndrome | Widespread Chronic Pain | Chronic Pain Due to InjuryUnited States
-
University of UtahRecruitingChronic Pain | Chronic Pain Syndrome | Widespread Chronic PainUnited States
-
Evolve Restorative CenterFlowonix Medical; Celéri Health, Inc.; Advanced Infusion SolutionsCompletedPain, Chronic | Pain, Intractable | Chronic Nonmalignant PainUnited States
-
Assiut UniversityNot yet recruiting
-
Atatürk Chest Diseases and Chest Surgery Training...RecruitingPostoperative Pain | Thoracotomy | Postoperative Pain, Acute | Postoperative Pain, ChronicTurkey
-
Istanbul UniversityCompletedLow Back Pain, Mechanical, Biofeedback, Pain, Chronic
-
Apurano Pharmaceuticals GmbHRecruitingPain | Lower Back Pain | Back Pain | Chronic Pain | Pain, Chronic | Chronic Pain Syndrome | Pain Syndrome | Lower Back Pain ChronicGermany
Clinical Trials on Exercise Group
-
University of ReginaUniversity of Saskatchewan; Saskatchewan Health Research Foundation; First Steps...RecruitingMultiple Sclerosis | Multiple Sclerosis, Chronic Progressive | Multiple Sclerosis, Relapsing-Remitting | Multiple Sclerosis, Secondary Progressive | Multiple Sclerosis, Primary ProgressiveCanada
-
University of Colorado, DenverTemple University; Virginia Commonwealth University; University of Colorado,... and other collaboratorsCompleted
-
Shanghai Pudong HospitalUnknown
-
Hasselt UniversityRecruitingGestational Hypertension | Cardiovascular Pregnancy ComplicationBelgium
-
Tel Aviv UniversityHadassah Medical Organization; Israel National Insurance InstituteRecruitingBreast Cancer | Colon CancerIsrael
-
University of OxfordOxford Brookes UniversityRecruitingOverweight/Obesity, AdolescentUnited Kingdom
-
Marmara UniversityRecruiting
-
Riphah International UniversityCompletedHypertension | ObesePakistan
-
University of ValenciaAsociación de Fibrosis Quística - Comunidad ValencianaNot yet recruiting
-
Eastern Mediterranean UniversityAkdeniz UniversityCompletedScoliosis Idiopathic | Scoliosis; AdolescenceTurkey